DUOL vs IONS · P/E 12, rev $590.4M vs rev $514.0M
Duolingo Inc (DUOL) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Duolingo Inc (DUOL) is a software - application company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported DUOL revenue for 2026-06-30 was $590.4M. Net income was $76.6M. DUOL currently screens at market cap $5.08B and trailing P/E 12.5.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
DUOL currently screens at market cap $5.08B and trailing P/E 12.5. IONS currently screens at market cap $12.28B.
Not investment advice. Open the DUOL and IONS stock pages for the full models.
Not investment advice.